0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hybrid Closed-Loop lnsulin Delivery System Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17R14490
Home | Market Reports | Health| Medical Devices & Equipment
Global Hybrid Closed Loop lnsulin Delivery System Market Research Report 2023
BUY CHAPTERS

Global Hybrid Closed-Loop lnsulin Delivery System Market Research Report 2025

Code: QYRE-Auto-17R14490
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hybrid Closed-Loop lnsulin Delivery System Market

The global market for Hybrid Closed-Loop lnsulin Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Hybrid Closed-Loop lnsulin Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hybrid Closed-Loop lnsulin Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hybrid Closed-Loop lnsulin Delivery System include Medtronic Inc., Insulet Corporation, Beta Bionics, EliLilly, WaveForm (AgaMatrix), Bigfoot Biomedical, Tandem Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hybrid Closed-Loop lnsulin Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hybrid Closed-Loop lnsulin Delivery System.
The Hybrid Closed-Loop lnsulin Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hybrid Closed-Loop lnsulin Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hybrid Closed-Loop lnsulin Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hybrid Closed-Loop lnsulin Delivery System Market Report

Report Metric Details
Report Name Hybrid Closed-Loop lnsulin Delivery System Market
Segment by Type
  • Type 1 Hybrid Closed Loop System
  • Type 2 Hybrid Closed Loop System
Segment by Application
  • Hospital
  • Private
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic Inc., Insulet Corporation, Beta Bionics, EliLilly, WaveForm (AgaMatrix), Bigfoot Biomedical, Tandem Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hybrid Closed-Loop lnsulin Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hybrid Closed-Loop lnsulin Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hybrid Closed-Loop lnsulin Delivery System Market report?

Ans: The main players in the Hybrid Closed-Loop lnsulin Delivery System Market are Medtronic Inc., Insulet Corporation, Beta Bionics, EliLilly, WaveForm (AgaMatrix), Bigfoot Biomedical, Tandem Inc.

What are the Application segmentation covered in the Hybrid Closed-Loop lnsulin Delivery System Market report?

Ans: The Applications covered in the Hybrid Closed-Loop lnsulin Delivery System Market report are Hospital, Private, Others

What are the Type segmentation covered in the Hybrid Closed-Loop lnsulin Delivery System Market report?

Ans: The Types covered in the Hybrid Closed-Loop lnsulin Delivery System Market report are Type 1 Hybrid Closed Loop System, Type 2 Hybrid Closed Loop System

1 Hybrid Closed-Loop lnsulin Delivery System Market Overview
1.1 Product Definition
1.2 Hybrid Closed-Loop lnsulin Delivery System by Type
1.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Type 1 Hybrid Closed Loop System
1.2.3 Type 2 Hybrid Closed Loop System
1.3 Hybrid Closed-Loop lnsulin Delivery System by Application
1.3.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Private
1.3.4 Others
1.4 Global Hybrid Closed-Loop lnsulin Delivery System Market Size Estimates and Forecasts
1.4.1 Global Hybrid Closed-Loop lnsulin Delivery System Revenue 2020-2031
1.4.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales 2020-2031
1.4.3 Global Hybrid Closed-Loop lnsulin Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hybrid Closed-Loop lnsulin Delivery System Market Competition by Manufacturers
2.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hybrid Closed-Loop lnsulin Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Date of Enter into This Industry
2.8 Global Hybrid Closed-Loop lnsulin Delivery System Market Competitive Situation and Trends
2.8.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hybrid Closed-Loop lnsulin Delivery System Players Market Share by Revenue
2.8.3 Global Hybrid Closed-Loop lnsulin Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hybrid Closed-Loop lnsulin Delivery System Market Scenario by Region
3.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Region: 2020-2031
3.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Region: 2020-2025
3.2.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Region: 2026-2031
3.3 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Region: 2020-2031
3.3.1 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Region: 2020-2025
3.3.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Region: 2026-2031
3.4 North America Hybrid Closed-Loop lnsulin Delivery System Market Facts & Figures by Country
3.4.1 North America Hybrid Closed-Loop lnsulin Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2031)
3.4.3 North America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hybrid Closed-Loop lnsulin Delivery System Market Facts & Figures by Country
3.5.1 Europe Hybrid Closed-Loop lnsulin Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2031)
3.5.3 Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hybrid Closed-Loop lnsulin Delivery System Market Facts & Figures by Country
3.7.1 Latin America Hybrid Closed-Loop lnsulin Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2020-2031)
4.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2020-2025)
4.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2026-2031)
4.1.3 Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Type (2020-2031)
4.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Type (2020-2025)
4.2.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Type (2026-2031)
4.2.3 Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Hybrid Closed-Loop lnsulin Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2020-2031)
5.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2020-2025)
5.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2026-2031)
5.1.3 Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Application (2020-2031)
5.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Application (2020-2025)
5.2.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Application (2026-2031)
5.2.3 Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Hybrid Closed-Loop lnsulin Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic Inc.
6.1.1 Medtronic Inc. Company Information
6.1.2 Medtronic Inc. Description and Business Overview
6.1.3 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.1.5 Medtronic Inc. Recent Developments/Updates
6.2 Insulet Corporation
6.2.1 Insulet Corporation Company Information
6.2.2 Insulet Corporation Description and Business Overview
6.2.3 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.2.5 Insulet Corporation Recent Developments/Updates
6.3 Beta Bionics
6.3.1 Beta Bionics Company Information
6.3.2 Beta Bionics Description and Business Overview
6.3.3 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.3.5 Beta Bionics Recent Developments/Updates
6.4 EliLilly
6.4.1 EliLilly Company Information
6.4.2 EliLilly Description and Business Overview
6.4.3 EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EliLilly Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.4.5 EliLilly Recent Developments/Updates
6.5 WaveForm (AgaMatrix)
6.5.1 WaveForm (AgaMatrix) Company Information
6.5.2 WaveForm (AgaMatrix) Description and Business Overview
6.5.3 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.5.5 WaveForm (AgaMatrix) Recent Developments/Updates
6.6 Bigfoot Biomedical
6.6.1 Bigfoot Biomedical Company Information
6.6.2 Bigfoot Biomedical Description and Business Overview
6.6.3 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.6.5 Bigfoot Biomedical Recent Developments/Updates
6.7 Tandem Inc.
6.7.1 Tandem Inc. Company Information
6.7.2 Tandem Inc. Description and Business Overview
6.7.3 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolio
6.7.5 Tandem Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hybrid Closed-Loop lnsulin Delivery System Industry Chain Analysis
7.2 Hybrid Closed-Loop lnsulin Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hybrid Closed-Loop lnsulin Delivery System Production Mode & Process Analysis
7.4 Hybrid Closed-Loop lnsulin Delivery System Sales and Marketing
7.4.1 Hybrid Closed-Loop lnsulin Delivery System Sales Channels
7.4.2 Hybrid Closed-Loop lnsulin Delivery System Distributors
7.5 Hybrid Closed-Loop lnsulin Delivery System Customer Analysis
8 Hybrid Closed-Loop lnsulin Delivery System Market Dynamics
8.1 Hybrid Closed-Loop lnsulin Delivery System Industry Trends
8.2 Hybrid Closed-Loop lnsulin Delivery System Market Drivers
8.3 Hybrid Closed-Loop lnsulin Delivery System Market Challenges
8.4 Hybrid Closed-Loop lnsulin Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hybrid Closed-Loop lnsulin Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hybrid Closed-Loop lnsulin Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hybrid Closed-Loop lnsulin Delivery System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hybrid Closed-Loop lnsulin Delivery System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hybrid Closed-Loop lnsulin Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hybrid Closed-Loop lnsulin Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hybrid Closed-Loop lnsulin Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Product Type & Application
 Table 12. Global Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hybrid Closed-Loop lnsulin Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hybrid Closed-Loop lnsulin Delivery System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hybrid Closed-Loop lnsulin Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Region (2020-2025)
 Table 19. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Region (2026-2031)
 Table 21. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Region (2020-2025)
 Table 23. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Region (2026-2031)
 Table 25. North America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hybrid Closed-Loop lnsulin Delivery System Sales (K Units) by Type (2020-2025)
 Table 51. Global Hybrid Closed-Loop lnsulin Delivery System Sales (K Units) by Type (2026-2031)
 Table 52. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2020-2025)
 Table 53. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2026-2031)
 Table 54. Global Hybrid Closed-Loop lnsulin Delivery System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hybrid Closed-Loop lnsulin Delivery System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Type (2020-2025)
 Table 57. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Type (2026-2031)
 Table 58. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hybrid Closed-Loop lnsulin Delivery System Sales (K Units) by Application (2020-2025)
 Table 61. Global Hybrid Closed-Loop lnsulin Delivery System Sales (K Units) by Application (2026-2031)
 Table 62. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2020-2025)
 Table 63. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2026-2031)
 Table 64. Global Hybrid Closed-Loop lnsulin Delivery System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hybrid Closed-Loop lnsulin Delivery System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Application (2020-2025)
 Table 67. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Application (2026-2031)
 Table 68. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Inc. Company Information
 Table 71. Medtronic Inc. Description and Business Overview
 Table 72. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product
 Table 74. Medtronic Inc. Recent Developments/Updates
 Table 75. Insulet Corporation Company Information
 Table 76. Insulet Corporation Description and Business Overview
 Table 77. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product
 Table 79. Insulet Corporation Recent Developments/Updates
 Table 80. Beta Bionics Company Information
 Table 81. Beta Bionics Description and Business Overview
 Table 82. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product
 Table 84. Beta Bionics Recent Developments/Updates
 Table 85. EliLilly Company Information
 Table 86. EliLilly Description and Business Overview
 Table 87. EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. EliLilly Hybrid Closed-Loop lnsulin Delivery System Product
 Table 89. EliLilly Recent Developments/Updates
 Table 90. WaveForm (AgaMatrix) Company Information
 Table 91. WaveForm (AgaMatrix) Description and Business Overview
 Table 92. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product
 Table 94. WaveForm (AgaMatrix) Recent Developments/Updates
 Table 95. Bigfoot Biomedical Company Information
 Table 96. Bigfoot Biomedical Description and Business Overview
 Table 97. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product
 Table 99. Bigfoot Biomedical Recent Developments/Updates
 Table 100. Tandem Inc. Company Information
 Table 101. Tandem Inc. Description and Business Overview
 Table 102. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product
 Table 104. Tandem Inc. Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Hybrid Closed-Loop lnsulin Delivery System Distributors List
 Table 108. Hybrid Closed-Loop lnsulin Delivery System Customers List
 Table 109. Hybrid Closed-Loop lnsulin Delivery System Market Trends
 Table 110. Hybrid Closed-Loop lnsulin Delivery System Market Drivers
 Table 111. Hybrid Closed-Loop lnsulin Delivery System Market Challenges
 Table 112. Hybrid Closed-Loop lnsulin Delivery System Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hybrid Closed-Loop lnsulin Delivery System
 Figure 2. Global Hybrid Closed-Loop lnsulin Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hybrid Closed-Loop lnsulin Delivery System Market Share by Type: 2024 & 2031
 Figure 4. Type 1 Hybrid Closed Loop System Product Picture
 Figure 5. Type 2 Hybrid Closed Loop System Product Picture
 Figure 6. Global Hybrid Closed-Loop lnsulin Delivery System Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hybrid Closed-Loop lnsulin Delivery System Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Private
 Figure 10. Others
 Figure 11. Global Hybrid Closed-Loop lnsulin Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hybrid Closed-Loop lnsulin Delivery System Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hybrid Closed-Loop lnsulin Delivery System Sales (2020-2031) & (K Units)
 Figure 14. Global Hybrid Closed-Loop lnsulin Delivery System Average Price (US$/Unit) & (2020-2031)
 Figure 15. Hybrid Closed-Loop lnsulin Delivery System Report Years Considered
 Figure 16. Hybrid Closed-Loop lnsulin Delivery System Sales Share by Manufacturers in 2024
 Figure 17. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hybrid Closed-Loop lnsulin Delivery System Players: Market Share by Revenue in Hybrid Closed-Loop lnsulin Delivery System in 2024
 Figure 19. Hybrid Closed-Loop lnsulin Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hybrid Closed-Loop lnsulin Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2020-2031)
 Figure 22. North America Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Region (2020-2031)
 Figure 34. China Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Hybrid Closed-Loop lnsulin Delivery System by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Hybrid Closed-Loop lnsulin Delivery System by Type (2020-2031)
 Figure 53. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Hybrid Closed-Loop lnsulin Delivery System by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Hybrid Closed-Loop lnsulin Delivery System by Application (2020-2031)
 Figure 56. Global Hybrid Closed-Loop lnsulin Delivery System Price (US$/Unit) by Application (2020-2031)
 Figure 57. Hybrid Closed-Loop lnsulin Delivery System Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart